Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
With a market cap of 998.46B, Eli Lilly(LLY) trades at $1,046.70. The stock has a price-to-earnings ratio of 46.12 and currently yields dividends of 56.7%.
On 2026-02-24, Eli Lilly(LLY) stock moved within a range of $1,015.23 to $1,054.58. With shares now at $1,046.70, the stock is trading +3.1% above its intraday low and -0.7% below the session's peak.
Trading volume for Eli Lilly(LLY) stock has reached 85.67K, versus its average volume of 3.22M.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.
Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,133.95 and a low of $623.78.
LLY News
Ozempic's list price is due to get cut, according to a report. Shares of Novo Nordisk and rival Eli Lilly fell on Tuesday after a report said price cuts are co...
Novo Nordisk (NVO) plans to cut U.S. list prices for Wegovy and Ozempic by up to half, effective January 1, 2027, The Wall Street Journal’s Peter Loftus reports...
Asad Haider, an analyst from Goldman Sachs, maintained the Buy rating on Eli Lilly & Co. The associated price target remains the same with $1,260.00. Asad Haid...
Analyst ratings
79%
of 33 ratingsMore LLY News
Ventyx Biosciences ( (VTYX) ) just unveiled an announcement. On January 7, 2026, Ventyx entered into a merger agreement under which Eli Lilly and Company will...
The company said the drug will be available at the same self-pay price in either the multi-dose pen or single-dose vial format, starting at $299 a month. brenda...
Eli Lilly Gains as Novo Nordisk Trial Setback Novo Nordisk’s stock hit a 52-week low after its REDEFINE 4 trial failed to demonstrate non-inferiority in weight...
Eli Lilly has some good news for investors today. Novo Nordisk has some bad news (which is also good news for Lilly). Eli Lilly (LLY +5.33%) stock, maker of th...
Eli Lilly (LLY) announced the FDA approved a label expansion for Zepbound to include the four-dose single-patient use KwikPen that delivers a full month of trea...
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York on March 28, 2024. Eli Lilly on Monday launched a new form of its blockb...
Biotech and Pharma Novo Nordisk Stock Plunges and Eli Lilly Jumps. It’s All Down to This Weight-Loss Drug Trial. In this article NVO LLY Novo Nordisk said on Mo...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.